Infliximab and Intravenous Gammaglobulin in Hospitalized Severe COVID-19 Patients in Intensive Care Unit.

Autor: Farrokhpour M; Department of Internal Medicine, Firoozgar Medical and Educational Hospital, Iran University of Medical Sciences, Tehran, Iran., Rezaie N; Department of Internal Medicine, Firoozgar Medical and Educational Hospital, Iran University of Medical Sciences, Tehran, Iran., Moradi N; Department of Internal Medicine, Firoozgar Medical and Educational Hospital, Iran University of Medical Sciences, Tehran, Iran., Ghaffari Rad F; Department of Internal Medicine, Firoozgar Medical and Educational Hospital, Iran University of Medical Sciences, Tehran, Iran., Izadi S; Department of Internal Medicine, Firoozgar Medical and Educational Hospital, Iran University of Medical Sciences, Tehran, Iran., Azimi M; Department of Internal Medicine, Firoozgar Medical and Educational Hospital, Iran University of Medical Sciences, Tehran, Iran., Zamani F; Gastrointestinal and liver Diseases Research Center, Iran University of Medical Sciences, Tehran, Iran., Izadi S; School of Public Health, Isfahan University of Medical Sciences, Isfahan, Iran., Ranjbar M; Antimicrobial Resistance Research Center, Iran University of Medical Sciences, Tehran, Iran., Jamshidi Makiani M; Antimicrobial Resistance Research Center, Iran University of Medical Sciences, Tehran, Iran., Laali A; Department of Infectious Diseases, Firoozgar Medical and Educational Hospital, Iran University of Medical Sciences, Tehran, Iran., Roham M; Antimicrobial Resistance Research Center, Iran University of Medical Sciences, Tehran, Iran., Yadollahzadeh M; Department of Internal Medicine, Firoozgar Medical and Educational Hospital, Iran University of Medical Sciences, Tehran, Iran.

Publikováno v: Archives of Iranian medicine [Arch Iran Med] 2021 Feb 01; Vol. 24 (2), pp. 139-143. Date of Electronic Publication: 2021 Feb 01.

Comprehensive review on repurposing of approved medicine in the management of COVID-19 infection.

Autor: Patel, Darshini¹, Shah, Umang¹ umangshah.ph@gmail.com, Patel, Arya¹, Patel, Sandip², Patel, Mehul¹, Patel, Ashish¹, Patel, Swayamprakash¹, Solanki, Nilay¹, Pandey, Nilesh³

Publikováno v: Organic Communications. Jan-Mar2022, Vol. 15 Issue 1, p1-31. 31p.

A fatal toxic shock-like syndrome post COVID-19 infection in a child.

Autor: Ajmi, Houda¹ (AUTHOR) hd.ajmi@gmail.com, Besghaier, Wissem¹ (AUTHOR), Kallala, Wafa² (AUTHOR), Trabelsi, Abdelhalim² (AUTHOR), Abroug, Saoussan¹ (AUTHOR)

Publikováno v: Italian Journal of Pediatrics. 6/2/2021, Vol. 47 Issue 1, p1-5. 5p.

COVID-19-associated opportunistic infections: a snapshot on the current reports.

Autor: Abdoli, Amir, Falahi, Shahab, Kenarkoohi, Azra

Publikováno v: Clinical & Experimental Medicine; Aug2022, Vol. 22 Issue 3, p327-346, 20p

Intravenous Immunoglobulin Therapy for Critically Ill COVID-19 Patients With Different Inflammatory Phenotypes: A Multicenter, Retrospective Study.

Autor: Chen, Yan, Xie, Jianfeng, Wu, Wenjuan, Li, Shusheng, Hu, Yu, Hu, Ming, Li, Jinxiu, Yang, Yi, Huang, Tingrong, Zheng, Kun, Wang, Yishan, Kang, Hanyujie, Huang, Yingzi, Jiang, Li, Zhang, Wei, Zhong, Ming, Sang, Ling, Zheng, Xia, Pan, Chun, Zheng, Ruiqiang

Publikováno v: Frontiers in Immunology; 1/27/2022, Vol. 13, p1-7, 7p